Efficacy and acceptability of interval fasting in cardiac rehabilitation - a randomized controlled trial

Not Applicable

• Conditions: I20-I25; E65-E68; Ischaemic heart diseases; Obesity and other hyperalimentation

• Registration Number: DRKS00023983
• Lead Sponsor: refonet Rehabilitations-Forschungsnetzwerk der Deutschen Rentenversicherung Rheinland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-02-17
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Male
• Target Recruitment: 100

Inclusion Criteria

BMI between 28 and 35 kg/m2

Exclusion Criteria

Excludes patients with addictive disorders, eating disorders, liver cirrhosis, renal insufficiency grade 4 or higher, severe obesity (BMI > 35 kg/m2), oncologic diseases, gastric/duodenal ulcers, or language impairment.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in weight relative to baseline weight during four weeks of inpatient rehabilitation.

Secondary Outcome Measures

Name	Time	Method
Changes in waist-to-hip ratio, body fat percentage, cholesterol, triglycerides, blood pressure, blood glucose, HOMA index, GGT, CRP during four weeks of rehabilitation compared to control group.